We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Refine your search

Content type

Tags

Author

732 results found

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

CNS drug approvals take longer, are rejected more often

A new Tufts Center for the Study of Drug Development report reveals that drugs to treat central nervous system (CNS) disorders take longer to develop

Article

Shook Hardy & Bacon LLP | USA, India | 13 Nov 2014

Ranbaxy loses FDA approval for two generics

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA)

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

News bytes

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry and staff titled "Molecular Diagnostic Instruments with Combined

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

Dissatisfied patent reexamination plaintiff contends standing conferred by statute

A consumer-interest organization that was dissatisfied by a Board of Patent Appeals and Interferences (BPAI) ruling in the appeal of a patent

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

RAND Corp. predicts $44.2 billion in savings with biosimilars

The Rand Corp. has issued a perspective titled "The Cost Savings Potential of Biosimilar Drugs in the United States." It predicts that "biosimilars

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

FTC settles deceptive sales-tactics claims against MPHJ Technology

The U.S. Federal Trade Commission (FTC) has agreed to settle claims that MPHJ Technology Investments, LLCa patent-assertion entity (PAE)and company

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

College research program partners with diagnostics firm

The Baylor College of Medicine and diagnostics company Miraca Holdings have reportedly formed a joint ventureBaylor Miraca Genetics

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

Ninth Circuit rules out state’s claims in class settlement with fetal-gender testing co

The Ninth Circuit Court of Appeals has enjoined California's effort to obtain restitution on behalf of individual citizens bound by the bargainedfor

Article

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

Bio-Rad agrees to pay $55 million to resolve SEC bribery charges

A California-based clinical diagnostic and life science research company has reportedly agreed to pay $55 million to resolve U.S. Securities and

Article

Shook Hardy & Bacon LLP | USA | 30 Oct 2014

Biotech boards dominated by men

A Liftstream analysis reportedly shows that the average Board of Directors in the biotechnology sphere is roughly 90 percent male and more than half

Previous page 1 2 3 ...